Form D · Biotechnology
MIgS LLC
Lebanon, NH · CIK 0001603109
Offering snapshot reported Mar 20, 2014 · SEC filing
- Reported sold
- $100K Offering amount: $100K
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Mar 10, 2014 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Mar 20, 2014 | Initial | $100,002 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-213963
Source: Form D, filed Mar 20, 2014. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Michael Feldhaus | Director, Executive |
| Claes Gustafsson | Director |
| James Marks | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
16 Cavendish Ct., Suite 227
Lebanon, NH, 03766
Lebanon, NH, 03766